SAA2 and Sepsis: Sander et al. [46] reported that SAA produced in the liver by hepatic IL6-gp130-STAT3 activation promoted anti-inflammatory properties by mobilizing myeloid-derived suppressor cells into the injured liver during sepsis, thus promoting survival.